Kronos Q324 sales volumes soared, offsetting flat TiO2 selling prices to deliver +22% YoY revenue growth along with improved profitability. The company faces high growth expectations as it integrates ...
Kronos' dividend cut and persistent negative free cash flow highlight ongoing financial strain, with no clear catalysts for improvement on the horizon. Dividend yield is now just 2.99%, lagging behind ...
We recently compiled a list of the 11 Best Small Cap Chemical Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Kronos Worldwide Inc. (NYSE:KRO) stands ...
$20,000 of KRONOS WORLDWIDE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to tax and tariff policy.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Kronos Bio, Inc. (NASDAQ: KRON) to Concentra Biosciences, LLC for $0.57 in cash per share plus one non-tradeable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results